COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,902 Articles (22,568 medRxiv, 8,334 bioRxiv)

Most recent first Previous |  Page 1233: Articles 12321-12330  | Next

High-Throughput Adaptable SARS-CoV-2 Screening for Rapid Identification of Dominant and Emerging Regional Variants
Hubler, Z., Song, X., Norris, C., Jani, M., Alouani, D., Atchley, M., Stempak, L. M., Cherian, S. S., Schmotzer, C. L., Sadri, N.
10.1101/2021.08.31.21262625 — Posted: 2021-09-02
Variant abundance estimation for SARS-CoV-2 in wastewater using RNA-Seq quantification
Baaijens, J. A., Zulli, A., Ott, I. M., Petrone, M. E., Alpert, T., Fauver, J. R., Kalinich, C. C., Vogels, C. B. F., Breban, M. I., Duvallet, C., McElroy, K., Ghaeli, N., Imakaev, M., Mckenzie-Bennett, M., Robison, K., Plocik, A., Schilling, R., Pierson, M., Littlefield, R., Spencer, M., Simen, B. B., Yale SARS-CoV-2 Genomic Surveillance Initiative, , Hanage, W. P., Grubaugh, N. D., Peccia, J., Baym, M.
10.1101/2021.08.31.21262938 — Posted: 2021-09-02 Discussion: Onsite
Psychological antecedents towards COVID-19 vaccination using the Arabic 5C validated tool: An online study in 13 Arab countries
Abdou, M. S., Kheirallah, K. A., Aly, M. O., Ramadan, A. M., Elhadi, Y. A. M., Elbarazi, I., Deghidy, E., El Saeh, H. M., Salem, K. M., Ghazy, R. M.
10.1101/2021.08.31.21262917 — Posted: 2021-09-02
How control and relaxation interventions and virus mutations influence the resurgence of COVID-19
Cao, L., Liu, Q.
10.1101/2021.08.31.21262897 — Posted: 2021-09-02
Fine analysis of lymphocyte subpopulations in SARS-CoV-2 infected patients: toward a differential profiling of patients with severe outcome
Clavarino, G., Leroy, C., Epaulard, O., Raskovalova, T., Vilotitch, A., Pernollet, M., Dumestre-Perard, C., Defendi, F., Le Marechal, M., Le Gouellec, A., Audoin, P., Bosson, J.-L., Poignard, P., Roustit, M., Jacob, M.-C., Cesbron, J.-Y.
10.1101/2021.08.31.21262538 — Posted: 2021-09-02
Pharmacokinetic /Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19
Leung, E., Jorgensen, S. C. J., Crass, R. L., Raybardhan, S., Langford, B., Moore, W. J., Rhodes, N. J.
10.1101/2021.08.28.21262692 — Posted: 2021-09-02
Early versus late third trimester maternal SARS-CoV-2 BNT162b2 mRNA immunization maximizes transplacental antibody transfer and neonatal neutralizing antibody levels
Rottenstreich, A., Zarbiv, G., Oiknine-Djian, E., Vorontsov, O., Zigron, R., Kleinstern, G., Wolf, D., Porat, S.
10.1101/2021.08.30.21262875 — Posted: 2021-09-02
Mapping interindividual dynamics of innate immune response at single-cell resolution
Kumasaka, N., Rostom, R., Huang, N., Polanski, K., Meyer, K., Patel, S., Boyd, R., Gomez, C., Barnett, S., Panousis, N., Schwartzentruber, J., Ghoussaini, M., Lyons, P. A., Calero-Nieto, F. J., Göttgens, B., Barnes, J. L., Worlock, K. B., Yoshida, M., Nikolic, M., Stephenson, E., Reynolds, G., Haniffa, M., Marioni, J., Stegle, O., Hagai, T., Teichmann, S. A.
10.1101/2021.09.01.457774 — Posted: 2021-09-01
The SARS-CoV-2 spike (S) and the orthoreovirus p15 cause neuronal and glial fusion
Martinez-Marmol, R., Giordano-Santini, R., Kaulich, E., Cho, A.-N., Riyadh, M. A., Robinson, E., Balistreri, G., Meunier, F. A., Ke, Y. D., Ittner, L. M., Hilliard, M. A.
10.1101/2021.09.01.458544 — Posted: 2021-09-01
Absence of severe COVID-19 in patients with clonal mast cells activation disorders: effective anti-SARS-CoV-2 immune response.
Rossignol, J., Ouedrani, A., Bulai-Livideanu, C., Barete, S., Terriou, L., Launay, D., Lemal, R., Greco, C., Frenzel, L., Meni, C., Bodemere-Skandalis, C., Polivka, L., Collange, A.-F., Hachichi, H., Bouzourine, S., Nait Messaoud, D., Negretto, M., Vendrame, L., Jambou, M., Gousseff, M., Durupt, S., Lega, J.-C., Durand, J.-M., GAUDY, C., Damaj, G., Gourin, M.-P., Hamidou, M., Bouillet, L., Le Mouel, E., Maria, A., Zunic, P., Cabrera, Q., Vincent, D., Lavigne, C., Riviere, E., Gourguechon, C., Brignier, A., Lhermitte, L., Molina, T. J., BRUNEAU, J., Agopian, J., Dubreuil, P., Ranta, D., Mania, A., Arock, M., Staropoli, I., Tournilhac, O., Lortholary, O., Schwartz, O., Chatenoud, L., Hermine, O.
10.1101/2021.09.01.458516 — Posted: 2021-09-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).